Jonathan G Drachman Neoleukin Therapeutics, Inc. (NLTX) insider trading activity

Jonathan G Drachman is President and CEO of Neoleukin Therapeutics, Inc.. Currently has a direct ownership of 2.35 Million shares of NLTX, which is worth approximately $0. The most recent transaction as insider was on Aug 24, 2021, when has been sold 100,000 shares (Common Stock) at a price of $6.11 per share, resulting in proceeds of $611,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.35M

0% 3M change

0% 12M change

Total Value Held $0

JONATHAN G DRACHMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 24 2021	BUY Open market or private purchase	$611,000 $6.11 p/Share	100,000 Added 4.08%	2,348,686 Common Stock
Jun 04 2021	BUY Open market or private purchase	$96,100 $9.61 p/Share	10,000 Added 0.44%	2,248,686 Common Stock
Jun 03 2021	BUY Open market or private purchase	$379,200 $9.48 p/Share	40,000 Added 1.76%	2,238,686 Common Stock

Also insider at

HARP

Harpoon Therapeutics, Inc. Healthcare

CALA

Calithera Biosciences, Inc. Healthcare

Director

JGD